Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal.
An intensive whirlwind year of study and productivity ended last week for 34 new graduates of the Master in Biomedical Innovation and Development program, who wrapped up their final projects and live presentations for assembled clinicians, faculty, industry leaders, fellow and former students.
Bilal Haider, assistant professor in the Wallace H.
Biomedical engineer Yonggang Ke, Ph.D., and colleagues at UC Davis and University of Washington were awarded a grant from the National Science Foundation to create DNA-based electrically readable memories.
The dream took hold when Ignacio Montoya was six-years-old and leaving his native Cuba, leaving behind his family, language, and culture. It happened right there on the Boeing airplane carrying he and his father to the United States.
James Dahlman, assistant professor in the Wallace H.
The Petit Institute for Bioengineering and Bioscience at the Georgia Institute of Technology experienced a dramatic expansion with the addition of 20 new faculty researchers.
The vision of making affordable, high-quality cell-based therapies available to hundreds of thousands of patients worldwide moved closer to reality June 6 with the dedication of a new cell manufacturing research facility at Georgia Tech aimed at changing the way we think about medical therapies.
Two multidisciplinary research teams have been awarded 2018 Petit Institute Seed Grants.
The National Science Foundation (NSF) has selected Georgia Tech Professor Branislav Vidakovic, who holds a joint appointment in the Stewart School of Industrial and Systems Engineering (ISyE) and the Wallace H.
Johnna Temenoff has been appointed to the Carol Ann and David D. Flanagan endowed professorship. Temenoff is a professor in the Wallace H.
Last year, commercial medical history was made when the Food and Drug Administration (FDA) approved the first gene therapy treatment, Kymriah, in the U.S., opening the door to a new world of treatment for devastating diseases.
Two years ago, Daniel Porada was sitting in a biology class at Columbia University when he came up with the idea for Synapse. He saw a way to leverage the krebs cycle (the process by which cells generate energy) for an energy drink.
A new national project, which includes the Georgia Institute of Technology, aims to convey the benefits of physics’ age-old intertwining with math upon biology, a science historically less connected with it.
Now in its sixth year, Project ENGAGES at the Georgia Institute of Technology has been around long enough to have some established traditions.
Ting works across multiple disciplines to advance mobility.
For Cassie Mitchell, predictive healthcare means using data analytics and computational approaches to best predict what care or treatment is going to work for a patient.
Faculty and staff in the Wallace H. Coulter Department of Biomedical Engineering (BME) at the Georgia Institute of Technology and Emory University gathered on the fourth floor of the Whitaker Building at Georgia Tech to give themselves a collective and well-earned pat on the back.
Congenital heart disease (CHD) affects nearly nine in every 1,000 babies born. In fact, it’s the world’s most common birth defect. Researchers and clinicians today have begun applying stem cell therapies and 3D tissue printing to pediatric heart defects.
More than 1 million Americans require daily physical assistance to get dressed because of injury, disease and advanced age. Robots could potentially help, but cloth and the human body are complex.